PODCAST
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
All Episodes
00:22:31
01:23:25
00:23:05
01:30:22
Zepbound Weight Loss and Cancer Diagnosis // OTP Eps 101
On The Pen With Dave Knapp
·
2025/02/14
en-us
00:30:52
01:13:37
00:33:03
Zepbound and Retatrutide News: Lilly Q4 Earnings Call...
On The Pen With Dave Knapp
·
2025/02/06
en-us
00:36:47
Novo Nordisk Q4 '24 Earnings Call: Obesity Medicine...
On The Pen With Dave Knapp
·
2025/02/05
en-us
00:24:02
01:29:05
00:20:02
503b Compounder Rocked by FDA Audit + OFA v FDA Trial...
On The Pen With Dave Knapp
·
2025/01/30
en-us
01:28:08
00:20:55
01:04:33
00:25:11
Compounders Win Small Battle in War Over Zepbound and...
On The Pen With Dave Knapp
·
2025/01/15
en-us
01:44:16
00:23:51
00:41:24
25:46
56:57